We are live on ! Find out more
LIP

Liontrust Investment Partners Portfolio holdings

AUM $6.8B
1-Year Est. Return 23.31%
This Fund
S&P 500
This Quarter Est. Return
+17.11%
1 Year Est. Return
+23.31%
3 Year Est. Return
+86.24%
5 Year Est. Return
+84.86%
10 Year Est. Return
–
AUM
$6.8B
AUM Growth
+$947M
Cap. Flow
+$302M
Cap. Flow %
4.44%
Top 10 Hldgs %
30.04%
Holding
242
New
46
Increased
60
Reduced
72
Closed
48

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$298M
2
DB icon
Deutsche Bank
DB
+$197M
3
SPOT icon
Spotify
SPOT
+$124M
4
UBS icon
UBS Group
UBS
+$112M
5
LIN icon
Linde
LIN
+$109M

Top Sells

Rank Stock Value
1
ARM icon
Arm
ARM
+$65.1M
2
INTU icon
Intuit
INTU
+$49.9M
3
PTC icon
PTC
PTC
+$39.9M
4
MU icon
Micron Technology
MU
+$39.2M
5
AMAT icon
Applied Materials
AMAT
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 27.9%
2 Healthcare 20.86%
3 Financials 15.39%
4 Industrials 12.21%
5 Communication Services 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
1
AstraZeneca
AZN
$252B
$297M 4.36%
+1,586,940
New +$298M
TSM icon
2
TSMC
TSM
$2.17T
$267M 3.93%
559,772
+39,214
+8% +$15.9M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$259M 3.8%
723,493
+82,440
+13% +$29.7M
AVGO icon
4
Broadcom
AVGO
$1.75T
$243M 3.57%
642,254
+22,702
+4% +$9.1M
DB icon
5
Deutsche Bank
DB
$75.8B
$205M 3.02%
+6,064,095
New +$197M
TMO icon
6
Thermo Fisher Scientific
TMO
$230B
$182M 2.67%
362,213
+101,547
+39% +$48.7M
V icon
7
Visa
V
$712B
$163M 2.39%
474,452
+5,323
+1% +$1.71M
CDNS icon
8
Cadence Design Systems
CDNS
$93.7B
$150M 2.2%
398,713
+30,538
+8% +$10.7M
WST icon
9
West Pharmaceutical
WST
$23.7B
$144M 2.12%
402,233
+65,238
+19% +$19.9M
WAT icon
10
Waters Corp
WAT
$40.7B
$135M 1.98%
358,979
+60,124
+20% +$20.5M
NVDA icon
11
NVIDIA
NVDA
$5.25T
$131M 1.93%
655,849
+46,063
+8% +$9.47M
UBS icon
12
UBS Group
UBS
$168B
$122M 1.79%
+2,458,659
New +$112M
SCHW
13
Charles Schwab
SCHW
$191B
$120M 1.77%
1,305,310
+102,662
+9% +$9.36M
MA icon
14
Mastercard
MA
$521B
$120M 1.76%
232,762
+377
+0.2% +$188K
SPOT icon
15
Spotify
SPOT
$113B
$119M 1.75%
+259,680
New +$124M
VLTO icon
16
Veralto
VLTO
$24B
$114M 1.68%
1,286,674
+77,927
+6% +$6.77M
ISRG icon
17
Intuitive Surgical
ISRG
$132B
$114M 1.67%
285,872
+20,909
+8% +$9.13M
IDXX icon
18
Idexx Laboratories
IDXX
$43.7B
$113M 1.66%
215,198
+37,861
+21% +$21.2M
CTAS icon
19
Cintas
CTAS
$81.7B
$113M 1.66%
663,625
+39,025
+6% +$6.75M
LIN icon
20
Linde
LIN
$226B
$111M 1.64%
+214,571
New +$109M
EW icon
21
Edwards Lifesciences
EW
$52B
$110M 1.62%
1,216,379
+78,008
+7% +$6.53M
MPWR icon
22
Monolithic Power Systems
MPWR
$61.7B
$105M 1.54%
75,786
+4,520
+6% +$6.79M
BDX icon
23
Becton Dickinson
BDX
$51.6B
$102M 1.5%
674,555
+29,247
+5% +$4.37M
EXC icon
24
Exelon
EXC
$45.3B
$97.7M 1.44%
2,096,030
+36,977
+2% +$1.71M
PGR icon
25
Progressive
PGR
$127B
$97.2M 1.43%
445,001
+133,951
+43% +$27M
1
2 3 4 5

Similar funds

TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Liontrust Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Liontrust Investment Partners held 242 positions worth $6.8B, up 16% from $5.86B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Liontrust Investment Partners deployed $302M of net new capital in Q2 2026, opening 46 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 1,586,940 shares worth $297M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arm, an estimated $65.1M trimmed.

  • Liontrust Investment Partners's largest Q2 2026 buy was AstraZeneca: 1,586,940 shares worth $297M.
  • Liontrust Investment Partners added most to Ferguson in Q2 2026, an estimated $79.5M increase.
  • Liontrust Investment Partners's biggest Q2 2026 reduction was Arm, cutting an estimated $65.1M.
  • Liontrust Investment Partners fully exited Ciena in Q2 2026, selling an estimated $31.9M.
  • Liontrust Investment Partners's ten largest holdings make up 30% of its $6.8B portfolio in Q2 2026.
  • Liontrust Investment Partners opened 46 new positions and closed 48 in Q2 2026.
  • Liontrust Investment Partners's portfolio value rose 16% quarter-over-quarter to $6.8B.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.